The Canadian Federal Government recently made a monumental decision, allowing four terminal cancer patients to legally use psilocybin to relieve their end-of-life anxiety. The exemption is a landmark recognition of the evidence for psilocybin as a powerful way for hospice patients to find acceptance of their mortality.
Psilocybin is the psychoactive compound found in magic mushrooms. Psilocybin has been shown to increase connectivity between neural processes. This can expand “brain plasticity,” potentially opening the mind to different perspectives. Peer-reviewed research has shown that using psilocybin can bring relief to people suffering depressive disorders by opening them to new ways of seeing the world and new self-awareness.